Stock listing
Anbio Biotechnology
Selected listing: A40J71 · LS · EUR · DE
Anbio Biotechnology (Lang & Schwarz: A40J71), Health Technology. Latest release Mar 17, 2026: Anbio Biotechnology to Participate in KeyBanc Capital Markets…
- Ticker
- Lang & Schwarz: A40J71
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Anbio Biotechnology
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
March 16, 2026
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025
October 7, 2025
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
August 7, 2025
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions
May 14, 2025
Anbio Biotechnology Announces Closing of Initial Public Offering
February 20, 2025
Research Anbio Biotechnology
Alternate listings
NNNN:NASDAQ
US · USD
Alternate listing for Anbio Biotechnology; the primary context on this page is A40J71:LS.
A40J71:LSX
DE · EUR
Alternate listing for Anbio Biotechnology; the primary context on this page is A40J71:LS.
NNNN:BOATS
US · USD
Alternate listing for Anbio Biotechnology; the primary context on this page is A40J71:LS.
N3B:FWB
DE · EUR
Alternate listing for Anbio Biotechnology; the primary context on this page is A40J71:LS.
N3B:TRADEGATE
DE · EUR
Alternate listing for Anbio Biotechnology; the primary context on this page is A40J71:LS.
N3B:DUS
DE · EUR
Alternate listing for Anbio Biotechnology; the primary context on this page is A40J71:LS.